Urine Osmolality Is a Potential Marker of Longer-Term Efficacy of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis.

ABSTRACT:

SUBMITTER: Ivaturi V 

PROVIDER: S-EPMC11296543 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature